This post was originally published on this site
Addiction Recovery Bulletin
ALCOHOLISM MEDICATION? –
Dec. 21, 2022 – The patent follows the appointment of former Red Bull Canada executive Nicholas Kadysh as special advisor on the regulatory development of MEAI.
Clearmind has been granted patent for MEAI-based alcohol substitute in Europe and India.
Click@SeekingAlpha
The post Clearmind Medicine Gets U.S. Patent for Psychedelic Drug to Treat Alcoholism appeared first on Addiction/Recovery eBulletin.